Envioneer엔바이오니아
317870 · KOSDAQ · ₩317870 · 엔바이오니아
₩4,765▲ ₩10 (0.21%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩14B | ₩14B | ₩15B | ₩11B | ₩8.9B |
| Cost of sales | ₩12B | ₩11B | ₩10B | ₩7.3B | ₩6.2B |
| Gross profit | ₩1.8B | ₩3.2B | ₩4.5B | ₩3.7B | ₩2.7B |
| Operating income | −₩6.2B | −₩2.1B | −₩205M | −₩701M | −₩767M |
| Net income | −₩11B | −₩2.1B | −₩3.9B | ₩74M | −₩2.4B |
| Net income to shareholders | −₩9.3B | −₩1.7B | −₩4.7B | −₩163M | −₩2.4B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩82B | ₩65B | ₩64B | ₩40B | ₩39B |
| Current assets | ₩18B | ₩11B | ₩24B | ₩18B | ₩16B |
| Cash and equivalents | ₩7.2B | ₩2.8B | ₩7.6B | ₩9.6B | ₩6.6B |
| Total liabilities | ₩47B | ₩19B | ₩22B | ₩19B | ₩20B |
| Current liabilities | ₩32B | ₩9.1B | ₩14B | ₩13B | ₩9.5B |
| Borrowings | ₩27B | ₩9.8B | ₩9.7B | ₩11B | ₩12B |
| Total equity | ₩36B | ₩46B | ₩42B | ₩21B | ₩18B |
| Shareholders' equity | ₩30B | ₩39B | ₩38B | ₩20B | ₩18B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩6.1B | −₩21M | ₩1.9B | ₩1.7B | −₩272M |
| Capital spending | ₩16B | ₩15B | ₩19B | ₩1.1B | ₩3.4B |
| Free cash flow | −₩22B | −₩15B | −₩17B | ₩613M | −₩3.7B |
Consolidated where available. Amounts in won.
Also known as: Envioneer / 엔바이오니아 / 317870 / KRX:317870
Source: KRX statistical information